Who invested in Talima Therapeutics?
Talima Therapeutics's investors include De Novo Ventures, U.S. Venture Partners, Latterell Venture Partners and Palo Alto Investors.
United States · Series B startup
2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$21Mraised across 2 rounds since 2005, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by venturebeat.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Talima Therapeutics's investors include De Novo Ventures, U.S. Venture Partners, Latterell Venture Partners and Palo Alto Investors.
Talima Therapeutics has raised $21M across 2 rounds since 2005.
Talima Therapeutics's most recent round was a Series B of $19M in May 2007.
Its most recent round, $19M in May 2007, is also its largest on record.
Talima Therapeutics's first round on record, in Apr 2005, was backed by De Novo Ventures and Palo Alto Investors.
Talima Therapeutics's latest named round is a Series B, in May 2007.
Talima Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.